Sort
11,323 grants matching “glioblastoma”
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
$812,211James R. Heath · Institute For Systems Biology · U01 · FY2018 · CA
Allogeneic glioma vaccine using TGF-beta knockouts
$810,121Habib Fakhrai · Novarx Corporation · R44 · FY2007 · CA
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
$809,915Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Allogeneic glioma vaccine using TGF-beta knockouts
$808,783Habib Fakhrai · Novarx Corporation · R44 · FY2008 · CA
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER
$808,473Haian Fu · Emory University · U01 · FY2013 · CA
Engraftment and in vivo selection of HIV-protected stem cells
$808,300Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2016 · HL
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$807,783William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Molecular MRI of Brain Metabolism Enabled by Long-Lived Spin States
$807,392Thomas Theis · North Carolina State University Raleigh · R01 · FY2020 · EB
Biomechanical properties of chromatin in cancer and normal cells
$806,473Yamini P Dalal · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Patient-specific predictive modeling that integrates advanced cancer imaging
$806,109Paul E Kinahan · University Of Washington · R01 · FY2013 · CA
Systematic Development of Novel, Druggable Cancer Targets
$805,604Michael E. Berens · Translational Genomics Research Inst · U01 · FY2015 · CA
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
$802,295Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Project 1: Analysis of cell autonomous mechanisms of phenotypic switching in invasive cancer models
$800,551Andre Levchenko · Yale University · U54 · FY2017 · CA
Development of Natural Product Leads as Anticancer Therapeutics
$798,286John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Advancing treatment and understanding of immunotherapy in glioblastoma
$796,871Nicholas A Butowski · University Of California, San Francisco · U19 · FY2024 · CA
SELF-NEUTRALIZING OLIGONUCLEOTIDES WITH ENHANCED CELLULAR UPTAKE
$796,420David R Tabatadze · Zata Pharmaceuticals, Inc. · R44 · FY2016 · GM
Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme
$796,215Stuart Marcus · Sonalasense Inc · R44 · FY2025 · CA
Translational Geroscience Network
$795,615James L. Kirkland · Cedars-Sinai Medical Center · R33 · FY2025 · AG
Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma
$794,779Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Systematic Development of Novel, Druggable Cancer Targets
$794,238Michael E. Berens · Translational Genomics Research Inst · U01 · FY2016 · CA
A MOUSE MODEL TO INVESTIGATE DIFFERENTIAL RESPONSE TO THERAPY AND MECHANISMS OF RECURRENCE IN GLIOBLASTOMA
$794,148Northwestern University · · FY2025 · Defense Health Agency
Engineering knotted peptide therapeutics for pediatric brain tumor patients
$793,459James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Engraftment and in vivo selection of HIV-protected stem cells
$792,237Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2015 · HL
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress
$790,576Christopher D Willey · University Of Alabama At Birmingham · U01 · FY2021 · CA
Engineering knotted peptide therapeutics for pediatric brain tumor patients
$789,957James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA